Adenosine Phosphate

Adenosine Phosphate

SCHEMBL8591984

CCCC[N+](CCCC)(CCCC)CCCC.Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O

nearest known ligand 0.81

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RY1 P47900 4/20 0.81
▸ P2RY2 P41231 3/20 0.81
▸ SRC P12931 2/20 0.81
▸ SMN1; SMN2 Q16637 2/20 0.81
▸ DNPH1 O43598 1/20 0.81
▸ PRKAB2 O43741 1/20 0.81
▸ TRPM2 O94759 1/20 0.81
▸ LDHA P00338 1/20 0.81
▸ ADRB2 P07550 1/20 0.81
▸ FBP1 P09467 1/20 0.81
▸ ADORA1 P30542 1/20 0.81
▸ PRKAG1 P54619 1/20 0.81
▸ PRKAA2 P54646 1/20 0.81
▸ PDE4D Q08499 1/20 0.81
▸ KCNH2 Q12809 1/20 0.81
▸ PRKAA1 Q13131 1/20 0.81
▸ PDE3A Q14432 1/20 0.81
▸ TAS1R3 Q7RTX0 1/20 0.81
▸ TAS1R1 Q7RTX1 1/20 0.81
▸ P2RY11 Q96G91 1/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Adenosine Phosphate SCHEMBL18917563 0.92 RXFP1 (0.77) P2RY1P2RY2SRCSMN1; SMN2DNPH1
Adenosine Phosphate SCHEMBL2515775 0.91 P2RY1 (0.81) P2RY1P2RY2SRCSMN1; SMN2DNPH1
Adenosine Phosphate SCHEMBL3176912 0.91 P2RY1 (0.98) P2RY1P2RY2SRCSMN1; SMN2DNPH1
Adenosine Phosphate SCHEMBL18454039 0.90 P2RY1 (0.89) P2RY1P2RY2SRCSMN1; SMN2DNPH1
Adenosine Phosphate SCHEMBL8903661 0.90 P2RY1 (0.92) P2RY1P2RY2SRCSMN1; SMN2DNPH1
Adenosine Phosphate SCHEMBL15646670 0.90 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2DNPH1
Adenosine Phosphate SCHEMBL2683103 0.90 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2DNPH1
Vidarabine Phosphate SCHEMBL144996 0.90 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2DNPH1
Adenosine Phosphate SCHEMBL5588 0.90 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2DNPH1
Adenosine Phosphate SCHEMBL14478782 0.90 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2DNPH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-10226696-A — — None — — JP disclosed
US-20170159112-A1 AMPLIFIED ISOTHERMAL DETECTION OF POLYNUCLEOTIDES WITH ATP RELEASE THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2017-06-08 — — US disclosed
JP-H10226696-A PRODUCTION OF AMP ALKYL ESTER DERIVATIVE FUSO YAKUHIN KOGYO KK 1998-08-25 — — JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170159112-A1 AMPLIFIED ISOTHERMAL DETECTION OF POLYNUCLEOTIDES WITH ATP RELEASE NT5C2, ATP5F1B, ATP5F1D P2RY1 133/4885P2RY2 214/4885SRC 4547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback